- Home
- SRE vs HLN Comparison
SRE vs HLN Comparison
Compare SRE & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRE
- HLN
- Stock Information
- Founded
- SRE 1998
- HLN 2022
- Country
- SRE United States
- HLN United Kingdom
- Employees
- SRE N/A
- HLN N/A
- Industry
- SRE Oil/Gas Transmission
- HLN Package Goods/Cosmetics
- Sector
- SRE Utilities
- HLN Consumer Discretionary
- Exchange
- SRE Nasdaq
- HLN Nasdaq
- Market Cap
- SRE 58.7B
- HLN 48.2B
- IPO Year
- SRE N/A
- HLN N/A
- Fundamental
- Price
- SRE $92.27
- HLN $8.79
- Analyst Decision
- SRE Buy
- HLN Hold
- Analyst Count
- SRE 12
- HLN 1
- Target Price
- SRE $85.42
- HLN N/A
- AVG Volume (30 Days)
- SRE 4.8M
- HLN 9.0M
- Earning Date
- SRE 11-05-2025
- HLN 07-31-2025
- Dividend Yield
- SRE 2.82%
- HLN 2.03%
- EPS Growth
- SRE N/A
- HLN 41.64
- EPS
- SRE 4.13
- HLN 0.23
- Revenue
- SRE $13,336,000,000.00
- HLN $15,096,588,575.00
- Revenue This Year
- SRE $9.18
- HLN $1.13
- Revenue Next Year
- SRE $5.73
- HLN $4.23
- P/E Ratio
- SRE $22.13
- HLN $19.08
- Revenue Growth
- SRE N/A
- HLN N/A
- 52 Week Low
- SRE $61.90
- HLN $8.71
- 52 Week High
- SRE $95.77
- HLN $11.42
- Technical
- Relative Strength Index (RSI)
- SRE 74.66
- HLN 33.51
- Support Level
- SRE $88.43
- HLN $8.71
- Resistance Level
- SRE $90.53
- HLN $8.98
- Average True Range (ATR)
- SRE 1.56
- HLN 0.11
- MACD
- SRE 0.62
- HLN -0.01
- Stochastic Oscillator
- SRE 96.71
- HLN 9.33
About SRE DBA Sempra
Sempra Energy serves one of the largest utility customer bases in the United States. It distributes natural gas and electricity in Southern California and owns 80% of Oncor, a transmission and distribution business in Texas. Sempra Infrastructure partners, of which Sempra will hold a 25% ownership, owns and operates liquefied natural gas facilities in North America and infrastructure in Mexico.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.